Our findings have implications for the understanding of tumor progression in MF in the early stages when malignant cells are sparse, when the skin architecture is preserved with the presence of normal fibroblasts, and when the immune infiltrate consists primarily of nonmalignant (reactive) Th1 cells and cytotoxic CD8+ T cells [3, 79]. The gene discussed is CD8A; the disease is mycosis fungoides.